84 related articles for article (PubMed ID: 7583212)
1. Haloperidol and reduced haloperidol-induced exacerbation of the dystonia produced by the kappa opioid U50,488H in guinea-pigs is associated with inhibition of sigma binding sites: behavioural and autoradiographical studies.
Brent PJ
Brain Res; 1995 Jul; 684(2):115-26. PubMed ID: 7583212
[TBL] [Abstract][Full Text] [Related]
2. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
Brent PJ
Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
[TBL] [Abstract][Full Text] [Related]
3. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
Brent PJ
Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
[TBL] [Abstract][Full Text] [Related]
4. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
5. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
[TBL] [Abstract][Full Text] [Related]
6. The kappa-opioid receptor agonist, U50,488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia.
Richter A; Löscher W
Eur J Pharmacol; 1993 May; 236(2):289-94. PubMed ID: 8391460
[TBL] [Abstract][Full Text] [Related]
7. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands.
de Costa BR; Bowen WD; Hellewell SB; George C; Rothman RB; Reid AA; Walker JM; Jacobson AE; Rice KC
J Med Chem; 1989 Aug; 32(8):1996-2002. PubMed ID: 2547074
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts.
Xia Q; Sheng JZ; Tai KK; Wong TM
J Pharmacol Exp Ther; 1994 Feb; 268(2):930-4. PubMed ID: 8114007
[TBL] [Abstract][Full Text] [Related]
11. Effects of prior exposure to morphine on the opioid inhibition of the stimulated release of [3H]norepinephrine from guinea pig cortex slices.
Werling LL; Brown SR; Cox BM
NIDA Res Monogr; 1986; 75():587-90. PubMed ID: 2829006
[TBL] [Abstract][Full Text] [Related]
12. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
Bhargava HN; Gulati A; Ramarao P
J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
[TBL] [Abstract][Full Text] [Related]
14. The effects of dynorphin A (1-13) and U50, 488H on free intracellular calcium in guinea pig cerebellar synaptosomes.
Olson KG; Welch SP
Life Sci; 1991; 48(6):575-81. PubMed ID: 1671526
[TBL] [Abstract][Full Text] [Related]
15. Kappa opioid receptor tolerance in the guinea pig hippocampus.
Jin W; Terman GW; Chavkin C
J Pharmacol Exp Ther; 1997 Apr; 281(1):123-8. PubMed ID: 9103488
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
Zhang WM; Wang HX; Xia Q; Wong TM
Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.
Belkowski SM; Alicea C; Eisenstein TK; Adler MW; Rogers TJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in U50,488H-induced phosphorylation of p44/42 mitogen-activated protein kinase in the guinea pig brain.
Rasakham K; McGillivray KL; Liu-Chen LY
Neuroscience; 2012 Oct; 223():447-56. PubMed ID: 22863678
[TBL] [Abstract][Full Text] [Related]
19. Haloperidol pretreatment unmasks the kappa opioid effects of U-50, 488H on cortical EEG and EEG power spectra in rats.
Young GA; Marquis KL; Paquette NC; Gussio RP; Khazan N
Neuropharmacology; 1989 Aug; 28(8):881-4. PubMed ID: 2550842
[TBL] [Abstract][Full Text] [Related]
20. In vivo treatment with mu and delta, but not kappa-selective opioid agonists reduces [3H]spiperone binding to the guinea-pig striatum: autoradiographic evidence.
Brent PJ; Bunn SJ
Brain Res; 1994 Aug; 654(2):191-9. PubMed ID: 7987668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
